Ylenia Lombardo
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.
Journal: Oncogene
Published: April 23, 2021
SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells.
SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells.
Journal: Cancer research
Published: August 05, 2020
Correction to: Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4.
Journal: Cell death and differentiation
Published: August 10, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion.
Journal: Nature communications
Published: August 08, 2019
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy.
Journal: Nature communications
Published: November 26, 2018
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.
Journal: PloS one
Published: June 23, 2017
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression.
Journal: Nature communications
Published: May 03, 2017
Mammosphere formation assay from human breast cancer tissues and cell lines.
Journal: Journal of visualized experiments : JoVE
Published: April 14, 2015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer.
Journal: Oncotarget
Published: March 11, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion.
Journal: Nature communications
Published: February 20, 2015
Last Updated: 09/26/2026